Bhaskar Anand - 02 Apr 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Accounting Officer
Signature
/s/ Bhaskar Anand
Issuer symbol
SMMT
Transactions as of
02 Apr 2024
Net transactions value
$0
Form type
4
Filing time
04 Apr 2024, 17:47:15 UTC
Previous filing
26 Sep 2023
Next filing
13 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +600,000 600,000 02 Apr 2024 Common Stock 600,000 $3.85 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on April 2, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 2, 2025. Note this does not include an additional 600,000 options which were granted on April 2, 2024 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets.
F2 Not applicable.